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Abstract
The mammalian Caudal-related homeobox transcription factor 2 (CDX2) plays a key role in
the homeobox regulatory network and is essential in regulating the expression of several
homeobox (HOX) genes during embryonic development, particularly in the gut. Genome-
wide CDX2 chromatin immunoprecipitation analysis and expression data from Caco2 cells
also suggests a role for CDX2 in the regulation of HOXB4 gene expression in the intestinal
epithelium. Thus, the aim of this study was to investigate whether HOXB4 gene expression
is regulated by CDX2 in the intestinal epithelium. We demonstrated binding of CDX2 to four
different CDX2 binding sites in an enhancer region located upstream of the HOXB4 tran-
scription start site. Mutations in the CDX2 binding sites reduced HOXB4 gene activity, and
knock down of endogenous CDX2 expression by shRNA reduced HOXB4 gene expres-
sion. This is the first report demonstrating the CDX2 regulation of HOXB4 gene expression
in the developed intestinal epithelium, indicating a possible role for HOXB4 in intestinal
homeostasis.
Introduction
Homeobox (HOX) proteins are important regulators during development and the formation
of the anterior and posterior body plane in vertebrates. The 39 differentHOX genes in humans
can be divided into four different clusters,HOXA,HOXB,HOXC andHOXD, which are
located on different chromosomes[1]. Each cluster contains 9–11HOX genes.HOX genes are
transcription factors belonging to the HOX protein family that share a DNA-binding domain,
termed the HOX domain. The HOX domain is comprised of 60 amino acids that bind DNA in
a sequence-dependentmanner[2]. In adults,HOX gene expression is organ-specific, and the
deregulation of specificHOX genes has been associated with cancer development[3]; these
genes includeHOXA9, which has been implicated in the development of acute myeloid leuke-
mia[4],HOXD3, which increases invasiveness and metastasis in lung cancer[5], and both
HOXA4 andHOXD10, which are overexpressed in colorectal cancer[6].
Another member of the HOX family is HOXB4, which is expressed in different tissues such
as colon and liver[7] and is a possible marker in cervical cancer[8]. In hematopoietic stem cells,
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overexpression of HOXB4 increases proliferation, and expression is regulated by the transcrip-
tion factor GATA-2[9]. However, despite the central role of HOXB4 in these processes, the reg-
ulation ofHOXB4 is still poorly understood.
The Caudal-related homeobox 2 (CDX2) gene is specifically expressed early after fertiliza-
tion in the trophectodermand is important for the correct formation of the blastocyst and sub-
sequent implantation in the uterus[10]. During later development, the CDX2 gene is
specifically expressed posteriorly in the tailbud. The gene encoding the transcription factor
CDX2 is also a member of the parahox gene family. DNA interactions mediated by the homeo-
domain of CDX2 can activate gene expression in a manner similar to the HOX proteins. CDX2
also plays an important role during development and establishment of the gastro-intestinal
tract, and loss of CDX2 during development is fatal[11]. Later in life, CDX2 expression is lim-
ited to the intestinal epithelium and plays an important role in maintaining the crypt/villus
axis and cellular differentiation along the axis[12]. Loss of Cdx2 expression in the mouse intes-
tinal epithelium inhibits the development of enterocytes and is fatal, underscoring the impor-
tance of CDX2 in intestinal homeostasis[13].Moreover, CDX2 acts as a tumor suppressor, and
inhibition of CDX2 expression increases the invasiveness of colon cancer[14].We conducted




SW480 (ATCC: CCL-228), Caco2 (ATCC: HTB-37) and HEK293 (ATCC: CRL-1573) cells
were cultured as monolayers in Dulbecco'sModified Eagle’s Medium (DMEM) supplemented
with 10% heat inactivated fetal calf serum (FCS), 100 μg/ml streptomycin and 100 U/ml peni-
cillin. All cell lines were cultured in a humidified atmosphere under 5% CO2.
Viral transduction and CDX2 knockdown
An SW480 cell line with stable CDX2 knock down was created using the lentiviral pLKO.1
puro shRNA expression vector. The shRNA expression vector (pLKO.1 puro) was a kind gift
from Dr. BobWeinberg (Plasmid #8453, Addgene, Cambridge,MA, USA)[15]. pLKO.1 puro
was digested with AgeI and EcoRI, and the DNA oligos CDX2 shRNA 735 Forward and CDX2
shRNA 735 Reverse were hybridized and inserted into pLKO.1. A lentiviral control vector con-
taining scrambled non-target shRNA (pLKO.1 scramble) was used as a negative control and
was a kind gift from Dr. David Sabatini (Plasmid #1864, Addgene)[16]. Next, 6x106 HEK293
cells were plated in 6-well plates one day prior to transfection.HEK293 were co-transfected
with either scrambled shRNA or CDX2 shRNA expressing lentivirus, psPAX, which was a gift
fromMalin Parmar (Plasmid #35002, Addgene), and pMD2.G, which was a gift from Didier
Trono (Plasmid #12259, Addgene). The transfectedHEK293 cells were maintained for 48
hours in DMEM supplemented with heat inactivated 10% FCS. The supernatant was then ster-
ile filtered using a 0.45-μM filter and added to 5x105 SW480 cells, followed by transduction for
24 hours. After 24 hours, the mediumwas replaced with DMEM supplemented with 10% heat
inactivated FCS and 10 μg/ml puromycin (Life Technologies, Carlsbad, CA, USA), and the
cells were reseeded twice per week for 3 weeks. Thereafter, cells were reseeded twice per week
and cultured in DMEM supplemented with 10% heat inactivated FCS.CDX2 knock down was
verified by RT-qPCR and western blotting.
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HOXB4 promoter/enhancer cloning
A potential CDX2 binding region in theHOXB4 enhancer was identified using previously pub-
lished chromatin immunoprecipitation-sequencing (ChIP-seq) data [17], which was uploaded
to the UCSCGenome Browser (version hg18).
The BAC clone RP11-111C6, which covers chromosome 17, positions ‒48583316 to ‒ 4857
8320 (GENBANK ID: NC_000017.11), was obtained from the BACPAC Resource Centre
(Oakland, CA, USA) and used as a template to amplify theHOXB4 promoter and enhancer
region. TheHOXB4 promoter and enhancer region was cloned using an In-Fusiontm cloning
kit (Clontech, Saint-Germain-en-Laye, France). A 4997-bp fragment was amplified using Phu-
sion HOTSTART II HD polymerase (Thermo Fisher Scientific,Waltham, MA, USA), the Infu-
sion HOXB4 Enhancer/promoter forward primer and the Infusion HOXB4 reverse primer
(Table 1). The pGL4.10 luciferase reporter plasmid (Promega, Nacka, Sweden) was digested
withHindIII according to the manufacturer’s protocol (Thermo Fisher Scientific), and the pro-
moter and enhancer were inserted using the In-Fusiontm HD cloning kit (Clontech) according
to the manufacturer’s protocol (Clontech). A 2850-bp fragment excluding the up-stream
CDX2 binding sites was amplified using Phusion HOTSTART II HD polymerase (Thermo
Table 1. DNA oligo sequences used in this study.
Name Sequence
CDX2 shRNA 735 Forward 5’- CGGCAAATATCGAGTGGTGTACACCTCGAGGTGTACACCACTCGATATTTGTTTTTG-‘3
CDX2 shRNA 735 Reverse 5’- AATTCAAAAACAAATATCGAGTGGTGTACACCTCGAGGTGTACACCACTCGATATTTG-‘3
Infusion HOXB4 Promoter Reverse Primer 5’-CCGGATTGCCAAGCTGGTGGTGTAATAAAAGTCCTTTTG-‘3
Infusion HOXB4 Enhancer/Promoter Forward Primer 5'-CTCGGCGGCCAAGCTATTGATGAGAACGATTCTTCGG-’3
Infusion HOXB4 Enhancer/Promoter Reverse Primer 5'-CCGGATTGCCAAGCTTAATTTCTGGGAATTGCCCACAAA-‘3.
Infusion HOXB4 Move Forward 5'-CTAGGCGAGTTCATA TATGTGTTTAGAAGGAAAGGAC-'3









EMSA Sucrase-isomaltase probe Forward 5’-ACTGACTTTATTAACTTTGTGACC-’3
EMSA Sucrase-isomaltase probe Forward 5’-AGGTCACAAAGTTAATAAAGTCAG-’3
EMSA unspecific probe Forward 5’-AACGTAGCTGATCGAATCGGTTAC-’3
EMSA unspecific probe Reverse 5’-AGTAACCGATTCGATCAGCTACGT-’3
HOXB4 ChIP PCR Forward 5'-GCCAGATGATATAGGGCCCC-'3
HOXB4 ChIP PCR Reverse 5'-AAGGTGGGGAAATGGGGTTC-'3
HOXB4 qPCR Forward 5'-CTGGATGCGCAAAGTTCAC
HOXB4 qPCR Reverse 5'-AGCGGTTGTAGTGAAATTCCTT-'3
CDX2 qPCR Forward 5'-ACTACAGTCGCTACATCACCA-'3
CDX2 qPCR Reverse 5'-GAAGACACCGGACTCAAGGG-'3
RPLP0 qPCR Forward 5'-GCAATGTTGCCAGTGTCTG-'3
RPLP0 qPCR Reverse 5'-GCCTTGACCTTTTCAGCAA-'3
HOXB4 CDX2 ChIP PCR Forward 5'-GCCAGATGATATAGGGCCCC-'3
HOXB4 CDX2 ChIP PCR Reverse 5'-AAGGTGGGGAAATGGGGTTC-'3
doi:10.1371/journal.pone.0164555.t001
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Fisher Scientific), the Infusion HOXB4 promoter forward primer and the Infusion HOXB4
promoter reverse primer (Table 1). The pGL4.10 luciferase reporter plasmid (Promega) was
digested withHindIII according to the manufacturer’s protocol (Fisher Scientific), and the
HOXB4 promoter was inserted using the In-Fusiontm HD cloning kit (Clontech) according to
the manufacturer’s protocol (Clontech)
CDX2 binding site mutations
Four different constructs containing theHOXB4 promoter/enhancer region (4997-bp frag-
ment) and in which each of the CDX2 binding sites, sequence a/cATAAAa/t[18], were replaced
with the EcoRI cleavage sequence, GAATTCG, were synthesized by Eurofins (Eurofins MWG
Operon, Ebersberg,Germany). The HOXB4 pGL4.10 reporter plasmid was digested withNdeI
(Thermo Fisher Scientific) and PsyI (Thermo Scientific) according to the manufacturer’s pro-
tocol. Each of the four CDX2 mutated constructs was used as template, and a 1724-bp fragment
containing the mutated CDX2 binding site was amplified using Phusion HotStart II polymer-
ase (Thermo Fisher Scientific), following the manufacturer’s protocol, and the Infusion
HOXB4 Move forward and reverse primers (Table 1). The fragments were inserted in the
NdeI- and PsyI-digestedHOXB4 pGL4.10 reporter plasmid using the In-Fusiontm HD cloning
kit (Clontech) according to the manufacturer’s instructions, resulting in four different plasmids
with each of the CDX2 binding sites mutated.
Reporter gene assays
One day prior to transfection, SW480 cells were seeded in 24-well plates at a density of 5x104
cells/well and transiently transfected the following day. The cells were transfected using polyethy-
lenimine at a final concentration of 2 μM and 0.3 μg DNA/well. Twenty-five nanograms of lucif-
erase reporter gene plasmid and 50 ng of β-galactosidase expression plasmid were used per well,
and the DNA concentration was adjusted to 0.3 μg with pBluescript SK+ (Stratagene, La Jolla,
CA, USA). Forty-eight hours post-transfection, cells were harvested and lysed; luciferase and β-
galactosidase activities were determined using the Dual Lighttm luminescent reporter gene assay
(Applied Biosystems, Naerum, Denmark), and luminescencewas determinedusing a GloMax1
96 Microplate Luminometer (Promega) according to the manufacturer’s instructions.
Protein extraction and immunoblotting
Total proteins were extracted from the lentiviral-modifiedshRNA-expressing SW480 cells
(scrambled shRNA or CDX2 shRNA) using Trizol (Life Technologies) as describedby the
manufacturer. Ten micrograms of total protein were analyzed by SDS-PAGE using a NuPAGE
4–12% Bis-Tris protein gel (Life Technologies) followed by transfer to a PVDFmembrane via
electroblotting using the iBlot Western blotting system (Life Technologies). The membrane
was incubated with primary antibodies against human CDX2 (1:300, mouse monoclonal, Bio-
Genex Laboratories, Fremont, CA) or glyceraldehyde 3-phosphate dehydrogenase (GAPDH,
1:300, mouse monoclonal, Millipore, Darmstad, Germany).
Electrophoretic mobility shift assay
The amplified region of theHOXB4 promoter and enhancer was analyzed using the JASPAR
database with a relative profile score threshold setting of 80% [19]. Four different probe sets
were designed to cover CDX2 binding sites in theHOXB4 enhancer at position ‒2662 to ‒2672
(site-4) on the minus strand, position ‒2737 to ‒2747 (site-3) on the plus strand, position ‒
2836 to ‒2846 (site-2) on the minus strand, and position ‒3030 to ‒3040 (site-1) on the plus
HOXB4 Gene Expression Is Regulated by CDX2 in Intestinal Epithelial Cells
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strand. The electrophoreticmobility shift assay (EMSA) was performed as previously described
[20]. Briefly, nuclear extracts from confluent Caco2 cells were incubated with p32-labeled
probes for site-1, -2, -3, or -4. A competition assay was performed using either an unlabeled
sucrase isomaltase probe containing a known CDX2 binding site (positive control) or unla-
beledHOXB4 probes corresponding to each of the four identified potential CDX2 binding sites
(site-1, -2, -3-, or -4). A supershift assay was performed using a human CDX2 antibody (Bio-
Genex) or influenza hemagglutinin (HA) as a negative control (describedbelow).
RNA extraction and RT-qPCR
Total RNA was extracted from SW480 cells using an E.Z.N.A. Total RNA KIT I (OMEGA
BIOTEK, Norcross, GA). RNA extractionwas performed according to the manufacturer’s
instructions. cDNA was synthesized according to the manufacturer’s instructions, using
qSCRIPT cDNA Supermix (Quanta Biosciences, Gaithersburg, MD). Relative quantification
was calculated using the ΔΔCT method, and ribosomal protein large P0 (RPLP0) was used as a
reference gene[21].
Chromatin immunoprecipitation
Confluent Caco2 cells were cross-linked, sonicated, and immunoprecipitated with an antibody
specific for either human CDX2 (BioGenex) or an antibody specific for the influenza hemag-
glutinin (HA) epitope (rabbit polyclonal α-HA; Santa Cruz Biotechnology Inc., Heidelberg,
Germany) as a negative control, as previously described[22].Purified immunoprecipitated
DNA was compared to input DNA, which corresponded to non-immunoprecipitated sheared
cross-linked chromatin, via qPCR analysis. The primers used to amplify the human genomic
sequences ofHOXB4 are listed in Table 1, and quantification of the chromatin immunoprecipi-
tation (ChIP)-DNA was performed using qPCR in triplicate with a Stratagene MX3002 (Strata-
gene) and a QuantiTect SYBR Green PCR Kit (Qiagen, Duesseldorf, Germany). Enrichment
was calculated as described elsewhere[23].
Statistical analysis
Statistical analysis was performed using unpaired Student’s t-tests, and values are shown as the
mean and standard deviation (SD). P-values of less than 0.05 were considered significant.
Results
CDX2 binds to the HOXB4 enhancer
Genome-wideCDX2 ChIP-seq data from a published report[17] on the intestinal cell line Caco2
revealed a potential CDX2 binding region in theHOXB4 enhancer, located from 2640 to 3050 bp
upstream of theHOXB4 transcription start site (Fig 1A). Thus, to verify whether CDX2 binds to
this region, we performedqPCR on chromatin obtained from Caco2 cells immunoprecipitated
with an anti-CDX2 or an anti-HA (negative control) antibody. In ChIP assays, chromatin
obtained from anti-CDX2 antibody immunoprecipitates showed significant enrichment of the
HOXB4 enhancer (49-fold, P<0.05) compared to the negative control (Fig 1B).
HOXB4 expression is modulated by CDX2
To determine whether endogenousHOXB4 expression is regulated by CDX2, we performed
stable shRNA-mediated knock down of endogenousCDX2 in SW480 cells. This cell line was
chosen because we were unable to generate a Caco2 cell line with stable CDX2 knock down, a
limitation that has also been reported by other groups[18]. In SW480 cells, endogenous CDX2
HOXB4 Gene Expression Is Regulated by CDX2 in Intestinal Epithelial Cells
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expression was effectively knocked down (Fig 2A). Moreover, both CDX2 andHOXB4mRNA
levels were decreased in SW480CDX2 compared to SW480NEG cells (data not shown), indicating
that CDX2 is involved in maintaining the endogenous expression ofHOXB4 in SW480 cells.
To verify the possible role of CDX2 in the regulation ofHOXB4 expression, a luciferase
reporter construct containing the human HOXB4 enhancer and promoter as well as another
construct containing only theHOXB4 promoter were created. The activity of the reporter con-
structs containing theHOXB4 promoter orHOXB4 promoter and enhancer were measured
both in SW480CDX2 and SW480NEG cells. TheHOXB4 promoter exhibited activity on its own
when comparing the expression levels in SW480CDX2 and SW480NEG cells (Fig 2B). The activ-
ity of the luciferase construct containing both theHOXB4 enhancer and promoter was signifi-
cantly reduced (P<0.01) when examining the expression levels in SW480CDX2 compared to
SW480NEG cells (Fig 2B). This result indicates that CDX2 is involved in the transcriptional reg-
ulation ofHOXB4.
To further investigate the role of CDX2 inHOXB4 expression, we performed a co-transfec-
tion experiment in SW480 cells. TheHOXB4 enhancer and promoter reporter construct was
Fig 1. Illustration of the CDX2 binding region in the HOXB4 enhancer region and analysis of CDX2
interactions with the HOXB4 enhancer region. Fig 1A) Genome browser CDX2 ChIP-seq peaks from a dataset
generated by Boyd et al.[17]. Fig 1B) ChIP-PCR with primers covering the CDX2 binding region within the HOXB4
enhancer. Equal amounts of input DNA were used for CDX2 ChIP-PCR. Hemagglutinin (HA) was used as a
negative control. The mean (n = 4) and SD are shown. *P< 0.05.
doi:10.1371/journal.pone.0164555.g001
HOXB4 Gene Expression Is Regulated by CDX2 in Intestinal Epithelial Cells
PLOS ONE | DOI:10.1371/journal.pone.0164555 October 18, 2016 6 / 12
transiently transfected into SW480 cells with or without the CDX2 expression plasmid.When
overexpressing CDX2, luciferase activity driven by theHOXB4 enhancer and promoter con-
struct was significantly higher (2.4-fold, P<0.01) relative to cells without co-transfection of the
CDX2 expression vector (Fig 2C).
CDX2 interacts with the HOXB4 enhancer region
We used computational DNA sequence analysis to identify potential CDX2 binding sites in the
HOXB4 enhancer region. This analysis revealed four predicted and potential CDX2 binding
sites within theHOXB4 enhancer region (Fig 3A). To further analyze the function of each of
the four CDX2 binding sites, mutations were introduced into each CDX2 binding site (HOXB4
site-1, -2, -3, and -4). The enhancer activity of each construct was measured using transient
transfection in SW480 cells, and mutation of all four sites individually significantly reduced
HOXB4 enhancer and promoter luciferase activity (P<0.01 for all) compared to the wild type
reporter construct (Fig 3B). When comparing the reduction in enhancer activity between the
four CDX2 binding sites, mutation ofHOBX4 site 2 reduced the activity to a lesser extent com-
pared toHOXB4 site-1, -3 and -4. (P<0.05)
In addition to the functional analysis of theHOXB4 enhancer/promoter constructs contain-
ing mutations within the CDX2 binding sites (HOXB4 site-1, -2, -3 or -4), we performed
EMSAwith oligonucleotides covering each of the four potential CDX2 binding sites and
nuclear extracts from Caco2 cells (Fig 3C–3F). The data revealed that all four probes were able
to induce the formation of a CDX2/DNA complex (Fig 3C–3F, lane 1). However, two non-spe-
cific complexes for site-3 and one non-specific complex for site-4 were revealed (Fig 3E and 3F,
lane 1, respectively). The binding specificity of these complexes was examined in competition
assays in which excess unlabeled cold probes, specifically a sucrose isomaltase probe, a probe
containing the CDX2 consensus sequence, or probes containing CDX2 binding site sequences
(HOXB4 site-1, -2, -3 or -4), or an unspecific oligonucleotide were utilized. UnlabeledHOXB4
site-2 and site-4 probes completely out-competed CDX2/DNA complexes (Fig 3C, lane 4, and
Fig 3E, lane 3). However, coldHOXB4 site-1 and site-3 probes only partially out-competed the
CDX2/DNA complex (Fig 3B, lane 2, and Fig 3D, lane 4). In contrast, the formation of the
CDX2/DNA complex was completely eliminated in all EMSAs by competition with the
Fig 2. The effects of CDX2 knock down and overexpression on HOXB4 expression in the SW480 cell line and functional analysis of 4 different
CDX2 binding sites in the HOXB4 enhancer region. Fig 2A) Western blot analysis of CDX2 expression levels in SW480 cells treated with scrambled
shRNA and cells in which CDX2 was knocked down. GADPH was used as a control to analyze equal amounts of total cellular protein. Fig 2B) The effects
of CDX2 knock down on the promoter activities of reporter constructs containing the HOXB4 promoter alone or the HOXB4 promoter including the
enhancer region. Fig 2C) Transient transfection of the HOXB4 promoter and enhancer reporter construct in SW480 cells with and without co-transfection
of a CDX2 expression plasmid. The mean (n = 4) and SD are shown. *P<0.05 and **P<0.01
doi:10.1371/journal.pone.0164555.g002
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Fig 3. Functional and EMSA analyses of CDX2 binding sites in the HOXB4 enhancer region. Fig 3A) Positions of the four potential
CDX2 binding sites and the EMSA probes covering these sites. Fig 3B) Reporter gene assays with four different luciferase constructs
containing the HOXB4 enhancer with wild-type CDX2 binding sites or four distinct reporter constructs containing individual mutations in the
four CDX2 binding sites (HOXB4 site-1, -2, -3 or 4). The mean (n = 4) and SD are shown. *P<0.05 and **P<0.01. Fig 3C–3F) EMSAs with
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unlabeled sucrase isomaltase probe (Fig 3B–3D, lane 3, and Fig 3E, lane 4), whereas the unspe-
cific probe did not affect CDX2/DNA complex formation (Fig 3C, lane 4, and Fig 3D and 3E,
lane 2).
To verify that CDX2 is present in the CDX2/DNA complex, supershift assays were per-
formed with anti-CDX2 and anti-HA (negative control) antibodies. The addition of an anti-
body against CDX2 effectively supershifted the CDX2/DNA complex in site-2, -3, and -4 (Fig
3C–3E, lane 5) but failed to supershift the CDX2/DNA complex in site-1 (Fig 3B, lane 6),
although a partial reduction in the band intensity of the CDX/DNA complex was observed.
Moreover, as expected, the CDX2/DNA complex did not supershift with the addition of an
antibody against HA (Fig 3C, lane 5, and Fig 3D and 3E, lane 6).
Discussion
The regulation ofHOXB4 expression is poorly understood in the intestinal epithelium and,
until now, no other transcription factors in the intestinal epithelium have been shown to
directly induceHOXB4 expression. Here, we demonstrate that CDX2 regulatesHOXB4 gene
expression in the intestinal epithelium-derived cell line SW480. Induction ofHOXB4 expres-
sion has previously been studied during fetal development, and expression is induced in the
hindbrain by retinoic acid. The induction of HOXB4 expression is mediated by the retinoic
acid response element located within theHOXB4 enhancer[24].HOXB4 is also expressed dur-
ing hematopoiesis and regulated by the transcription factor GATA-2 in hematopoietic stem
cells and progenitor cells[9].
A reduction inHOXB4 expression levels, achieved using siRNA-mediated CDX2 knock
down in the COLO320 cell line, has previously been demonstrated[25]. In the present study,
we made similar observations in two different cell lines, Caco2 and SW480, both derived from
colorectal cancers. However, Salari et al. did not investigate the possible CDX2-mediated
induction of HOXB4. We demonstrate CDX2 binding to the HOXB4 enhancer region by
ChIP-PCR and we have identified four CDX2 binding sites and performed a functional analysis
of each site. Mutating each of the 4 sites significantly reduces enhancer activity compared to
controls, but not equally. Mutating the HOXB4 site-2 affects promoter activity to a lesser extent
compared to the mutation of HOXB4 site-1, HOXB4 site-3 and HOXB4 site-4.
Previous studies of CDX1, 2 and 4 have shown that they bind to the promoter of HOXA5,
and it has been suggested that CDX4 modulates HOXA5 expression during embryonic devel-
opment[26]. CDX2 expression along the crypt-villus axis varies, with the lowest CDX2 expres-
sion at the bottom of the crypt and increased expression during cellular differentiation[27].
The expression of HOXA5 also varies and increases during differentiation[28], and it is possi-
ble that the expression is mediated by CDX2. HOXA5 has been suggested to be a potential
tumor suppressor in breast cancer[29]. CDX has also been shown to regulate HOXB8 expres-
sion during embryonic development. Furthermore, in vitro binding of CDX1, CDX2 and
CDX4 has been described, and binding has been demonstrated by all three CDX transcription
factors in vivo[30].
HOXB4 binding sites have been investigated in hematopoietic stem cells and progenitor
cells, and HOXB4 has been shown to both up- and down-regulate the expression of target
genes[31]. However, the binding of HOXB4 is dependent not only on HOXB4 but also on sev-
eral different co-factors. These co-factors form complexes with HOB4 and are members of the
probes for the four different CDX2 binding sites (HOXB4 site-1, -2, -3 and 4). One hundred-fold unlabeled probe was added to the
competition reactions as well as sucrase isomaltase (SI) or unspecific probe (unspec). Influenza hemagglutinin (HA) antibody (negative
control) or CDX2 antibody (CDX2) was used in the supershift assay. Non-specific bands and supershifts indicated by black arrows.
doi:10.1371/journal.pone.0164555.g003
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TALE family, includingMEIS, PBX and PREP, which play important roles in target sequence
selection and binding[32]. However, the intestinal expression levels of these co-factors remain
unclear and must be investigated to identify HOXB4 target genes in the intestinal epithelium.
The function of the CDX2-mediated induction of HOXB4 in intestinal differentiation and
homeostasis is not known. AsHOX genes are transcription factors, their downstream targets
must be identified to clarify the function of HOXB4 expression in the intestinal epithelium. It is
possible that HOXB4 induction plays a role in cellular differentiation or intestinal homeostasis.
We show that CDX2 binds to the HOXB4 enhancer, regulates HOXB4 expression in intesti-
nal-derived epithelial cell lines, and has a possible role in the regulation of HOXB4 expression
in the intestinal epithelium and intestinal homeostasis.
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